pregnancy | CARLAT PUBLISHING

Psychopharm Commandment #9: Meds to Avoid in Pregnancy

May 22, 2023

Chris Aiken, MD and Kellie Newsome, PMHNP

Why valproate is the #1 contraindicated med in pregnancy, and what are the other close contenders.

CARLAT WEBINAR

Treatment of Bipolar Disorder in Pregnant and Postpartum Women

March 10, 2023

Victoria Hendrick, MD

What are the risks associated with pharmacologic treatments of bipolar disorder in pregnancy? This webinar will arm clinicians with the knowledge to prescribe (or not to prescribe) during pregnancy.

CARLAT WEBINAR

Frequently Overlooked Considerations in Women's Mental Health

January 10, 2023

Victoria Hendrick, MD

A summary of some of the current research findings in psychiatric treatment relating to women's mental health.

Breastfeeding and Psychiatric Medications

December 19, 2022

Chris Aiken, MD and Kellie Newsome, PMHNP

The FDA has a new rating system for breastfeeding risks with medications. We look at what that changes for psychotropics.

Pregnancy and Psychiatric Medications

December 12, 2022

Chris Aiken, MD and Kellie Newsome, PMHNP

Updates on the management of psych meds during pregnancy and breastfeeding, with help from Anita Clayton, MD

Pregnancy and PMDD at the Mood Summit

December 5, 2022

Chris Aiken, MD and Kellie Newsome, PMHNP

This podcast brings you up to date on how to manage premenstrual dysphoric disorder and safe prescribing during pregnancy.

CARLAT WEBINAR

Treatment of Depression During Pregnancy

September 13, 2022

Victoria Hendrick, MD

How to have a discussion with patients and to document risks and benefits to educate them the baseline risk of depression treatment in pregnancy.

Lithium Exposure In Utero—How Bad Is It Really?

July 1, 2022

Victoria Hendrick, MD and Lara Tang, MD

Lara Tang, MD, and Victoria Hendrick, MD. Dr. Tang and Dr. Hendrick have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

We know prenatal lithium exposure increases the risk of heart defects in newborns. By keeping lithium doses and blood levels under certain cut-off points, we can reduce this risk, according to this large meta-analysis.

Unintended Pregnancies in Opioid Use Disorder

March 1, 2022

Peter J. Farago, MD.

Peter J. Farago, MD. Dr. Farago has disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Rates of unintended pregnancies are high among patients with opioid use disorder (OUD). In this study, researchers tested the efficacy of co-locating contraceptive services with treatment for OUD as well as the efficacy of providing financial incentives.

The Pregnant Patient With Substance Use Disorder

July 3, 2021

Ariadna Forray, MD

Ariadna Forray, MD
Associate Professor of Psychiatry, Yale School of Medicine, New Haven, CT. Interim Chief, Section of Psychological Medicine. Director, Center for Wellbeing of Women and Mothers, Yale New Haven Hospital. Dr. Forray has disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Dr. Forray gives readers a comprehensive refresher on fetal effects of alcohol, tobacco, opioid, cannabis, and stimulant use during pregnancy. She then lays out the current evidence for various treatments and provides recommendations for how to treat pregnant patients with addiction.